In a cross-sectional study evaluating the effect of SGLT2 inhibitors on insulin secretion and resistance, SGLT2 inhibitors blunted glucagon-induced insulin secretion in β-cells and improved insulin resistance [249]. This evidence concerns the gene SLC5A2 and Insulin resistance.